Substrate
science

Study Finds Seasonal Patterns in Children's Vaccine Antibody Responses

A review of 96 trials covering 48,000 children found stronger antibody responses to several vaccines during winter months in temperate regions. Near the equator, responses showed annual swings but peaked at different times depending on the vaccine.

New Scientist
1 source·May 27, 11:20 PM(1 day ago)·1m read
Study Finds Seasonal Patterns in Children's Vaccine Antibody Responsesoneindia.com
Audio version
Tap play to generate a narrated version.

A pooled analysis of 96 randomized controlled trials found that the time of year children received vaccines against polio, measles, chickenpox and other diseases was associated with differences in the strength of their antibody response. The study examined data from roughly 48,000 children across multiple countries and seasons.

Researchers excluded participants who already had antibodies to the target pathogens before vaccination.

In temperate zones of both hemispheres, antibody responses were generally stronger during winter months. Closer to the equator, the timing of peak responses varied by vaccine, with some showing larger seasonal swings than others. The pattern held after accounting for prior exposure, though the study did not identify the exact environmental or biological drivers.

"We found that there is indeed a seasonal immune response," said Laura Barrero Guevara of New York University. Cathy Wyse of the University of Edinburgh, who was not involved in the work, said the results suggest human immune function differs across seasons, similar to patterns observed in other species.

The researchers noted that differences in antibody levels do not necessarily mean differences in protection from disease, and they advised against delaying scheduled vaccinations to chase possible seasonal gains.

Key Facts

96 trials
randomized controlled trials analyzed
48,000 children
total participants across all trials
Temperate regions
stronger winter antibody responses observed
Tropical regions
peak timing varied by vaccine type

Story Timeline

2 events
  1. 2026

    Researchers pooled data from 96 vaccine trials involving 48,000 children.

    1 source@NewScientist
  2. 2020

    Earlier study reported seasonal changes in inflammatory markers and immune cells.

    1 source@NewScientist

Potential Impact

  1. 01

    Further studies could test whether specific vaccines produce measurably different protection by season.

  2. 02

    Public health agencies may review whether current vaccination schedules align with observed seasonal patterns.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count200 words
PublishedMay 27, 2026, 11:20 PM
Bias signals removed1 across 1 outlet
Signal Breakdown
Editorializing 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source